Atara BiotherapeuticsATRA
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 34 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings, down 10 from Q2 2024. 3 opened new positions and 13 sold out. The largest holders were EcoR1 Capital, LLC ($3.8M), Redmile Group, LLC ($3.7M) and Citadel Advisors ($2.1M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Atara Biotherapeutics Inc.
- CUSIP
- 046513206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $12K |
| Exits | 13 | $2.7M |
All 13F filers, Q2 2024 → Q3 2024: 223,368 shares bought and 462,643 shares sold, net −239,275 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| EcoR1 Capital, LLC | 0.13% | Add +15.3% | 468,938 | $3.8M |
| Redmile Group, LLC | 0.22% | No change | 452,270 | $3.7M |
| Citadel Advisors | 0.00% | No change | 260,480 | $2.1M |
| Bank of America Corp. | 0.00% | Add +9.5% | 203,627 | $1.7M |
| Vanguard Group Inc. | 0.00% | Add +6.7% | 180,715 | $1.5M |
| Millennium Management | 0.00% | Add +50.9% | 176,053 | $1.4M |
| Acadian Asset Management LLC | 0.00% | Add +8.2% | 129,144 | $1.0M |
| Vestal Point Capital, LP | 0.08% | Add +11.3% | 124,677 | $1.0M |
| Tang Capital Management LLC | 0.04% | No change | 75,196 | $611K |
| Renaissance Technologies | 0.00% | Add +47.0% | 67,734 | $551K |
| BlackRock, Inc. | 0.00% | — | 60,954 | $496K |
| Geode Capital Management, LLC | 0.00% | Add +9.5% | 46,720 | $380K |
| Centiva Capital, LP | 0.02% | Reduce -69.0% | 43,403 | $353K |
| Staley Capital Advisers Inc. | 0.01% | No change | 40,000 | $325K |
| FMR LLC | 0.00% | Add +41.8% | 25,061 | $204K |
| State Street Corp. | 0.00% | Add +52.3% | 22,353 | $182K |
| Morgan Stanley | 0.00% | Add +65.5% | 16,189 | $132K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 14,000 | $114K |
| JPMorgan Chase & Co. | 0.00% | Reduce -17.5% | 1,370 | $11K |
| Wells Fargo & Company | 0.00% | Add +297.1% | 1,251 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -83.2% | 752 | $6K |
| Global Retirement Partners, LLC | 0.00% | New | 750 | $6K |
| Russell Investments Group, Ltd. | 0.00% | Add +35850.0% | 719 | $6K |
| Osaic Holdings, Inc. | 0.00% | New | 644 | $5K |
| UBS Group AG | 0.00% | Reduce -0.3% | 402 | $3K |
| Group One Trading LLC | 0.00% | Reduce -91.8% | 394 | $3K |
| IFP Advisors, Inc | 0.00% | No change | 180 | $1K |
| Rhumbline Advisers | 0.00% | Reduce -74.3% | 175 | $1K |
| Lazard Asset Management LLC | 0.00% | Reduce -58.1% | 129 | $1K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 100 | $813 |
| BNP Paribas Financial Markets | 0.00% | Reduce -99.8% | 56 | $455 |
| GAMMA Investing LLC | 0.00% | New | 56 | $455 |
| Citigroup Inc. | 0.00% | Reduce -99.8% | 8 | $65 |
| Royal Bank of Canada | 0.00% | Reduce -99.2% | 17 | $0 |
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.